Behzad Aghazadeh - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Behzad Aghazadeh has filed 3 SEC Form 4 filings across 2 companies in the last 90 days - buying. Lifetime open-market purchases: $36.26M.
Profile
Behzad Aghazadeh is a corporate insider at Whitehawk Therapeutics, Inc. (WHWK). Aghazadeh has reported 1 insider filing with the SEC since 2026. The most recent filing was in June 2026.
| Role | Director, 10% Owner |
|---|---|
| Notability | 20/100 |
Board memberships
- Whitehawk Therapeutics, Inc.
Trading Pattern
InsiderAlpha's records for Behzad Aghazadeh go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $12.09M (3 buys totaling $36.26M). The largest single buy on record is $35.00M of SCTX in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Behzad Aghazadeh has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director, 10% Owner at Scribe Therapeutics, Inc. (SCTX) - 1 filing, 2026
- Director at Scribe Therapeutics, Inc. (SCTX) - 1 filing, 2026
- Insider at Whitehawk Therapeutics, Inc. (WHWK) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-29 | SCTX | Scribe Therapeutics, Inc. | P - Open-market purchase | 7.9K | $18.25 | $144K |
| 2026-07-29 | SCTX | Scribe Therapeutics, Inc. | P - Open-market purchase | 50.0K | $22.31 | $1.12M |
| 2026-07-29 | SCTX | Scribe Therapeutics, Inc. | P - Open-market purchase | 2.33M | $15.00 | $35.00M |
Companies - Last 90 Days
- Scribe Therapeutics, Inc. (SCTX) - 2 filings, last 2026-07-29
- Whitehawk Therapeutics, Inc. (WHWK) - 1 filing, last 2026-06-15
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Behzad Aghazadeh has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Carl L. Gordon - $15.00M of SCTX open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $15.00M of SCTX open-market activity in the last 12 months
- AH Bio Fund II, L.P. - $5.00M of SCTX open-market activity in the last 12 months
- David James Lennon - $1.06M of WHWK open-market activity in the last 12 months
- Scott M. Giacobello - $891K of WHWK open-market activity in the last 12 months
- Bryan Ball - $635K of WHWK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Marc Benioff
- BERKSHIRE HATHAWAY INC
- Paul L. Berns
- Sardar Biglari,
- Chester Billingsley
- BITMINE IMMERSION TECHNOLOGIES, INC.
- BlackRock Portfolio Management LLC
- Blackstone Holdings I L.P.
Frequently Asked Questions
Who is Behzad Aghazadeh?
Behzad Aghazadeh is a corporate insider at Whitehawk Therapeutics, Inc. (WHWK). Aghazadeh has reported 1 insider filing with the SEC since 2026. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Behzad Aghazadeh submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Behzad Aghazadeh been buying or selling stock?
Recorded transactions: 3 open-market purchases ($36.26M) and 0 open-market sales across all tracked filings.
Where can I see all of Behzad Aghazadeh's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Behzad Aghazadeh profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.